New JDRF Fundraising Initiative is Zipping through the Country; Aims to Raise $1 Million for Type 1 Diabetes Research
JDRF’s innovative Zip the Cure campaign allows donors to sponsor a zip code, with all funds benefiting research toward curing, better treating, and preventing type 1 diabetes
Joana Casas, 212-479-7560; email@example.com
New York, NY, March 17, 2011 — JDRF’s Zip the Cure campaign is aiming high in 2012, with a goal of raising $1 million for research toward curing, better treating, and preventing type 1 diabetes (T1D) and its complications. The innovative fundraising initiative allows people to sponsor a United States zip code for $50, either individually or as part of a group. Sponsors will “own” — and can even name — their sponsored zip code until January 1, 2013, with the option of renewing their sponsorship the following year. The goal is to raise $1 million in sponsored zip codes for 2012.
“Zip the Cure is an incredible example of the power of creative fundraising,” said Jennifer Fishkind, Director of Team JDRF. “It is a simple yet fun way to get people involved in JDRF’s cause. We have a ways to go before reaching our million-dollar goal this year, but we’re optimistic that together we will get there. We are excited to watch the United States map on the Zip the Cure website flood with blue as more sponsors join us.”
Zip the Cure is the brainchild 17-year-old Monica Oxenreiter from Pittsburgh, PA, who at 13 months old was diagnosed with T1D — an autoimmune disease with no known cause or cure in which the body’s pancreas stops producing insulin. Monica’s brother, John, was diagnosed three years later at the age of eight. The siblings were both delegates of JDRF’s Children’s Congress in 2005, an event that further spurred their desire to help JDRF in its mission of supporting research toward curing T1D and its complications. Monica created the idea for Zip the Cure, and the campaign launched on World Diabetes Day, November 14, 2009. To date, Zip the Cure has already raised more than $98,000 for type 1 diabetes research.
To learn more about JDRF’s Zip the Cure campaign, and to sponsor your very own zip code, visit www.zipthecure.com.
In T1D, a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. People with T1D need to test their blood sugar and give themselves insulin (with injections or an insulin pump) multiple times every day, and carefully balance insulin doses with eating and daily activities throughout the day and night. However, insulin is not a cure for diabetes, and even with that intensive care, a significant portion of the day is still spent with either high or low blood sugar, placing people with T1D at risk for devastating complications such as heart attack, stroke, blindness, and amputation.
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.
Since its founding in 1970, JDRF has awarded more than $1.7 billion to diabetes research. Past JDRF efforts have helped to significantly advance the care of people with this disease, and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered. More than 80 percent of JDRF’s expenditures directly support research and research-related education.